Activation and evasion of type I interferon responses by SARS-CoV-2

Xiaobo Lei; Xiaojing Dong; Ruiyi Ma; Wenjing Wang; Xia Xiao; Zhongqin Tian; Conghui Wang; Ying Wang; Li Li; Lili Ren; Fei Guo; Zhendong Zhao; Zhuo Zhou; Zichun Xiang; Jianwei Wang

doi:10.1038/s41467-020-17665-9

Keywords

Evasion (ethics)Interferon type IVirologySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)InterferonCoronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakBiologyImmunologyMedicineImmune systemOutbreakDiseaseInfectious disease (medical specialty)

Affiliated Institutions

Related Publications

Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study

Qingxian Cai , Minghui Yang , Dongjing Liu +23 more

There is currently an outbreak of respiratory disease caused by a novel coronavirus. The virus has been named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and th...

2020 Engineering 1386 citations

SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness

Kaichun Wu , Carole Henry , Kapil Bahl +59 more

A vaccine for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is needed to control the coronavirus disease 2019 (COVID-19) global pandemic. Structural studies have ...

2020 Nature 1567 citations

Return of the Coronavirus: 2019-nCoV

Lisa E. Gralinski , Vineet D. Menachery

The emergence of a novel coronavirus (2019-nCoV) has awakened the echoes of SARS-CoV from nearly two decades ago. Yet, with technological advances and important lessons gained f...

2020 Viruses 1421 citations

SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract

Yixuan J. Hou , Kenichi Okuda , Caitlin E. Edwards +40 more

The mode of acquisition and causes for the variable clinical spectrum of coronavirus disease 2019 (COVID-19) remain unknown. We utilized a reverse genetics system to generate a ...

2020 Cell 1608 citations

SARS-CoV-2 vaccines in development

Florian Krammer

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first reported in late 2019 in China and is the causative agent of the coronavirus disease 2019 (COVID-19) pande...

2020 Nature 2193 citations

Publication Info

Year: 2020
Type: article
Volume: 11
Issue: 1
Pages: 3810-3810
Citations: 1040
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Activation and evasion of type I interferon responses by SARS-CoV-2

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

1040

OpenAlex

Cite This

APA Style

                            
                                
                                    Xiaobo Lei, 
                                
                                    Xiaojing Dong, 
                                
                                    Ruiyi Ma
                                
                                et al.
                            
                            (2020). 
                            Activation and evasion of type I interferon responses by SARS-CoV-2. 
                            Nature Communications
                            , 11
                            (1)
                            , 3810-3810.
                            https://doi.org/10.1038/s41467-020-17665-9
                        

Identifiers

DOI: 10.1038/s41467-020-17665-9